Leslie Molony
Plus aucun poste en cours
Profil
Leslie Molony was the founder of Sunesis Pharmaceuticals, Inc. (founded in 2003) and Transgeneron Therapeutics, Inc. (founded in 2007), where she held the title of Principal and President & Chief Executive Officer respectively.
She also held former positions as Chief Executive Officer at St. Charles Pharmaceuticals, Consultant at EDB Business Partner ASA and ProPharma Partners Ltd., Principal at GlaxoSmithKline, Inc. and Tanabe Research Laboratories U.S.A., Inc., and Senior Vice President-Business Development at Resilience Government Services, Inc. Dr. Molony received her undergraduate and doctorate degrees from Duke University.
Anciens postes connus de Leslie Molony
| Sociétés | Poste | Fin |
|---|---|---|
Resilience Government Services, Inc.
 Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Corporate Officer/Principal | - |
| St. Charles Pharmaceuticals | President | - |
Recombinant Capital, Inc.
 Recombinant Capital, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Recombinant Capital, Inc. is a private company that provides life sciences subscription database and advisory services. The company is based in Walnut Creek, CA. The company was founded by Mark G. Edwards. Recombinant Capital was acquired by Deloitte Touche Tohmatsu Services LLC on June 16, 2008. | Corporate Officer/Principal | - |
| VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
ProPharma Partners Ltd.
 ProPharma Partners Ltd. Miscellaneous Commercial ServicesCommercial Services ProPharma Partners Ltd. provides pharmaceutical and biotechnological consulting services. It helps its clients to develop and implement their strategic, business development, and clinical plans. The company is headquartered in Crawley, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Leslie Molony
| Duke University | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Transgeneron Therapeutics, Inc.
 Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transgeneron Therapeutics, Inc. researches and develops therapies to treat diseases. It develops therapeutic medicine that promotes tissue regeneration by reprogramming healthy tissue. This therapeutic reprogramming causes cells to 'trans-differentiate' into cells that can replace diseased or degenerated organs. The company was founded in April 2007 and is located in Gainesville, FL | Health Technology |
EDB Business Partner ASA
 EDB Business Partner ASA Information Technology ServicesTechnology Services EDB Business Partner ASA engages in the sale of software, information technology solutions and consulting services, as well as the centralized and decentralized operation of computer systems. It also offers outsourcing services and services related to data communication, data security and electronic publishing. The company was founded in 1961 and is headquartered in Oslo, Norway | Technology Services |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
ProPharma Partners Ltd.
ProPharma Partners Ltd. Miscellaneous Commercial ServicesCommercial Services ProPharma Partners Ltd. provides pharmaceutical and biotechnological consulting services. It helps its clients to develop and implement their strategic, business development, and clinical plans. The company is headquartered in Crawley, the United Kingdom. | Commercial Services |
Tanabe Research Laboratories U.S.A., Inc.
 Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The private company is based in San Diego, CA. | Health Technology |
| St. Charles Pharmaceuticals | |
Recombinant Capital, Inc.
Recombinant Capital, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Recombinant Capital, Inc. is a private company that provides life sciences subscription database and advisory services. The company is based in Walnut Creek, CA. The company was founded by Mark G. Edwards. Recombinant Capital was acquired by Deloitte Touche Tohmatsu Services LLC on June 16, 2008. | Commercial Services |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Health Technology |
